Correspondence Activity Detail
Annovis Bio, Inc. (ANVS)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 30, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Annovis Bio, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company that it is responsible for the accuracy and … | Read Filing EDGAR |
| Sep. 29, 2025 | CORRESP | Neutral/Informational | Moderate | Annovis Bio, Inc. has responded to the SEC's request for clarification regarding the breakdown of expenses related to its Alzheimer's and Parkinson's studies as stated in their Fo… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.